NP Medical News about cost-effectiveness

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Use of Antiemetic Agents in Acute Gastroenteritis

3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

4. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

5. Rapid correction of low vitamin D status in nursing home residents

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Preventing panic disorder: cost-effectiveness analysis alongside a pragmatic randomised trial
Cost Effectiveness and Resource Allocation, 04/29/09

Smit F et al. - The median incremental cost-effectiveness ratio is E6,198 per PD-free survival gained, which has a likelihood of 75.2% of being more acceptable from a cost-effectiveness point of view than care-as-usual when a willingness-to-pay ceiling is assumed of E10,000 per PD-free survival. The most significant cost driver was therapists' time. A sensitivity analysis indicated that cost-effectiveness improves when the number of therapist hours is reduced.

<< Previous
Profit, Sales Increase for CPSI

Next >>
Contraception and women over 40 years of age: mixed-method...